Volume 28, Issue 3 (7-2020)
Avicenna J Nurs Midwifery Care 2020, 28(3): 251-262 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Rezaian Langroudi R, Ghiasian M, Roozbehani M, Shamsaei F. Comparison of the Effectiveness of Group Therapy Based on Acceptance and Commitment and Amantadine on Pain, Fatigue and Quality of Life in Patients with Multiple Sclerosis. Avicenna J Nurs Midwifery Care 2020; 28 (3) :251-262
URL: http://nmj.umsha.ac.ir/article-1-2292-en.html
URL: http://nmj.umsha.ac.ir/article-1-2292-en.html
1- PhD student in Psychology, Department of Psychology, Borujerd, Branch, Islamic Azad University, Borujerd, Iran.
2- Assistant Professor, Department of Neurology, Faculty of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran ,Masoud_ghiasian2000@yahoo.com
3- Assistant Professor, Department of Physical Education, Faculty of Humanities, Borujerd Azad University, Borujerd , Iran
4- Associate Professor, Department of Nursing, School of Nursing and Midwifery, Hamadan University of Medical Sciences, Hamadan, Iran
2- Assistant Professor, Department of Neurology, Faculty of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran ,
3- Assistant Professor, Department of Physical Education, Faculty of Humanities, Borujerd Azad University, Borujerd , Iran
4- Associate Professor, Department of Nursing, School of Nursing and Midwifery, Hamadan University of Medical Sciences, Hamadan, Iran
Abstract: (3286 Views)
Introduction: Multiple sclerosis (MS) is the most common progressive neurological disease in which the myelin of the central nervous system is destroyed and causes many problems for the affected person and is one of the most important life-changing diseases, especially at a young age which causes a severe reduction in the level of individual performance. The aim of this study was to compare the effectiveness of group therapy based on acceptance and commitment and amantadine on pain, fatigue and quality of life in patients with MS.
Methods: The present quasi-experimental study was performed with a pre- and post-test design. Statistical population included all people with MS in Hamadan province, Iran; 60 female patients who met the inclusion criteria were randomly selected and divided into two equal groups undergoing treatment based on acceptance and commitment (act) and taking amantadine for 3 months. Subjects completed the fatigue severity scale (FSS-9), multiple sclerosis impact scale (MSIS-29), and McGill Pain before and after treatment. Data were analyzed using ANOVA, covariance, Kruskal-Wallis, LSD and Bonferroni statistical methods using SPSS software version 22.
Results: The findings showed that the difference between amantadine consumption and act with the superiority of amantadine effect over act on pain, fatigue and quality of life was not significant (P<0.001).
Conclusion: It can be concluded that non-pharmacological therapies can also be used as adjunctive therapy along with medical therapies.
Methods: The present quasi-experimental study was performed with a pre- and post-test design. Statistical population included all people with MS in Hamadan province, Iran; 60 female patients who met the inclusion criteria were randomly selected and divided into two equal groups undergoing treatment based on acceptance and commitment (act) and taking amantadine for 3 months. Subjects completed the fatigue severity scale (FSS-9), multiple sclerosis impact scale (MSIS-29), and McGill Pain before and after treatment. Data were analyzed using ANOVA, covariance, Kruskal-Wallis, LSD and Bonferroni statistical methods using SPSS software version 22.
Results: The findings showed that the difference between amantadine consumption and act with the superiority of amantadine effect over act on pain, fatigue and quality of life was not significant (P<0.001).
Conclusion: It can be concluded that non-pharmacological therapies can also be used as adjunctive therapy along with medical therapies.
Keywords: Amantadine, Fatigue, Pain, Acceptance and Commitment Psychotherapy, Quality of Life, Multiple Sclerosis
Type of Study: Original Research |
Subject:
Nursing
Received: 2020/02/29 | Accepted: 2020/07/6 | Published: 2020/10/31
Received: 2020/02/29 | Accepted: 2020/07/6 | Published: 2020/10/31
References
1. Wendebourg MJ, Heesen C, Finlayson M, Meyer B, Pöttgen J, Köpke S. Patient education for people with multiple sclerosis-associated fatigue: a systematic review. PLoS One. 2017 Mar 7;12(3):e0173025. [DOI:10.1371/journal.pone.0173025] [PMID] [PMCID]
2. Dobryakova E, Genova HM, DeLuca J, Wylie GR. The dopamine imbalance hypothesis of fatigue in multiple sclerosis and other neurological disorders. Frontiers in neurology. 2015 Mar 12;6:52. [DOI:10.3389/fneur.2015.00052] [PMID] [PMCID]
3. Khabaronline. 70 Thousands MS Patients in Iran; 2017 [cited 2018 Feb. 2]. Available form: https://www.khabaronline.ir/detail/539288/society/health.
4. Blankespoor RJ, Schellekens MP, Vos SH, Speckens AE, de Jong BA. The effectiveness of mindfulness-based stress reduction on psychological distress and cognitive functioning in patients with multiple sclerosis: a pilot study. Mindfulness. 2017 Oct;8(5):1251-8. [DOI:10.1007/s12671-017-0701-6] [PMID] [PMCID]
5. Induruwa I, Constantinescu CS, Gran B. Fatigue in multiple sclerosis-a brief review. Journal of the neurological sciences. 2012 Dec 15;323(1-2):9-15. [DOI:10.1016/j.jns.2012.08.007] [PMID]
6. Thomas PW, Thomas S, Kersten P, Jones R, Slingsby V, Nock A, et al. One year follow-up of a pragmatic multi-centre randomised controlled trial of a group-based fatigue management programme (FACETS) for people with multiple sclerosis. BMC Neurol. 2014;14:109. [DOI:10.1186/1471-2377-14-109] [PMID] [PMCID]
7. Buhrman M, Skoglund A, Husell J, Bergström K, Gordh T, Hursti T, Bendelin N, Furmark T, Andersson G. Guided internet-delivered acceptance and commitment therapy for chronic pain patients: a randomized controlled trial. Behaviour research and therapy. 2013 Jun 1;51(6):307-15. [DOI:10.1016/j.brat.2013.02.010] [PMID]
8. Aghili SM, Afzali S. The Effect of Yoga Yoga Breathing Exercises on chronic Low Pain, Anxiety, Psychological and Physical Well-being of Women with MS. Quarterly Journal of Health Psychology. 2017 Mar 8;5(20):109-24.
9. Ledinek AH, Sajko MC, Rot U. Evaluating the effects of amantadin, modafinil and acetyl-L-carnitine on fatigue in multiple sclerosis-result of a pilot randomized, blind study. Clinical neurology and neurosurgery. 2013 Dec 1;115:S86-9. [DOI:10.1016/j.clineuro.2013.09.029] [PMID]
10. Möller F, Poettgen J, Broemel F, Neuhaus A, Daumer M, Heesen C. HAGIL (Hamburg Vigil Study): a randomized placebo-controlled double-blind study with modafinil for treatment of fatigue in patients with multiple sclerosis. Multiple Sclerosis Journal. 2011 Aug;17(8):1002-9. [DOI:10.1177/1352458511402410] [PMID]
11. Zhou HY, Chen SR, Pan HL. Targeting N-methyl-D-aspartate receptors for treatment of neuropathic pain. Expert Rev Clin Pharmacol. 2011 May 1;4(3):379-88. [DOI:10.1586/ecp.11.17] [PMID] [PMCID]
12. Hawton K, Salkours K, Clarck. Congnitive behavior Therapy for psychiatric problems, a practical guide. Translated by: Ghasem zadeh H. Tehran: Arjmand Publication (2003)[Persian].
13. Khazaei M, Karevan A, Taheri M, Ghafouri-Fard S. Comparison of the effects of amantadine and ondansetron in treatment of fatigue in patients with multiple sclerosis. Clinical and translational medicine. 2019 Dec;8(1):1-5. [DOI:10.1186/s40169-019-0239-4]
14. Nasiri A, Kazemi-Zahrani H. The effectiveness of group acceptance and commitment therapy on pain intensity, pain catastrophizing and pain-associated anxiety in patients with chronic pain. Asian Social Science. 2015 Nov 1;11(26):112. [DOI:10.5539/ass.v11n26p112]
15. Potter KJ, Golijana-Moghaddam N, Evangelou N, Mhizha-Murira JR, Das Nair R. Self-help acceptance and commitment therapy for carers of people with multiple sclerosis: A feasibility randomised controlled trial. Journal of clinical psychology in medical settings. 2020 Mar 6:1-6. [DOI:10.1007/s10880-020-09711-x] [PMID]
16. Trompetter HR, Bohlmeijer ET, Fox JP, Schreurs KM. Psychological flexibility and catastrophizing as associated change mechanisms during online Acceptance & Commitment Therapy for chronic pain. Behaviour research and therapy. 2015 Nov 1;74:50-9. [DOI:10.1016/j.brat.2015.09.001] [PMID]
17. Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD. The fatigue severity scale: application to patients with multiple sclerosis and systemic lupus erythematosus. Archives of neurology. 1989 Oct 1;46(10):1121-3. [DOI:10.1001/archneur.1989.00520460115022] [PMID]
18. Ghazagh M, Zadhasan Z. The Effect of Group Mindfulness-Based Stress Reduction Program on the Quality of Life and Fatigue in Patients With Multiple Sclerosis. Avicenna Journal of Nursing and Midwifery Care. 2019 Mar 10;27(1):35-44. [DOI:10.30699/ajnmc.27.1.35]
19. Kargarfard M, Eetemadifar M, Mehrabi M, Maghzi AH, Hayatbakhsh MR. Fatigue, depression, and health‐related quality of life in patients with multiple sclerosis in Isfahan, Iran. European journal of neurology. 2012 Mar;19(3):431-7. [DOI:10.1111/j.1468-1331.2011.03535.x] [PMID]
20. Digiulio M, Jackson D. Pain Nursing Process and Pain Treatment. (Translation: Mohammad Zul-Adl and Givi). 2015. Tehran: Tarjamak Publications.
21. Vakili N, Asgari K, Kalantari M, Molavi H, Asheghan M. The Effect of Alexithymia, Anxiety, and Depression on Pain Severity in Female Patients with Fibromyalgia in Tehran. The Neuroscience Journal of Shefaye Khatam. 2015 Dec 10;3(4):49-56. [DOI:10.18869/acadpub.shefa.3.4.49]
22. Jewaltz T, Hayes SC. Act. (Translation: Ali Akbar Seif). 2013. Tehran: Didar Publications.
23. Nourbakhsh B, Revirajan N, Morris B, Cordano C, Creasman J, Manguinao M, et al. Safety and efficacy of amantadine, modafinil, and methylphenidate for fatigue in multiple sclerosis: a randomised, placebo-controlled, crossover, double-blind trial. Lancet Neurol. 2021;20(1):38-48. [DOI:10.1016/S1474-4422(20)30354-9]
24. Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD. The fatigue severity scale: application to patients with multiple sclerosis and systemic lupus erythematosus. Archives of neurology. 1989 Oct 1;46(10):1121-3. [DOI:10.1001/archneur.1989.00520460115022] [PMID]
25. Hayes SC, Levin ME, Plumb-Vilardaga J, Villatte JL, Pistorello J. Acceptance and commitment therapy and contextual behavioral science: Examining the progress of a distinctive model of behavioral and cognitive therapy. Behavior therapy. 2013 Jun 1;44(2):180-98. [DOI:10.1016/j.beth.2009.08.002] [PMID] [PMCID]
26. Davoodi M, Shameli L, Hadianfard H. The Effectiveness of Acceptance and Commitment Therapy on Chronic Fatigue Syndrome and Pain Perception in People With Multiple Sclerosis. IJPCP. 2019; 25 (3) :250-265 [DOI:10.32598/ijpcp.25.3.250]
27. Eilenberg T, Fink P, Jensen JS, Rief W, Frostholm L. Acceptance and commitment group therapy (ACT-G) for health anxiety: a randomized controlled trial. Psychol Med. 2016;46(1):103-15. [DOI:10.1017/S0033291715001579] [PMID]
28. Cohen RA, Fisher M. Amantadine treatment of fatigue associated with multiple sclerosis. Archives of neurology. 1989 Jun 1;46(6):676-80. [DOI:10.1001/archneur.1989.00520420096030] [PMID]
29. Twohig MP, Levin ME. Acceptance and commitment therapy as a treatment for anxiety and depression: a review. Psychiatric clinics. 2017 Dec 1;40(4):751-70. [DOI:10.1016/j.psc.2017.08.009] [PMID]
30. Bach P, Hayes SC. The use of acceptance and commitment therapy to prevent the rehospitalization of psychotic patients: a randomized controlled trial. J Consult Clin Psychol. 2002 Oct;70(5):1129. [DOI:10.1037/0022-006X.70.5.1129] [PMID]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
Articles Copyright © The Author(s).
Owned by Hamadan University of Medical Sciences.
Published by UMSHA Press
Journal Tel: +9881 38380150
Publisher Tel: +988138381795
Website: http://nmj.umsha.ac.ir
Email: managingeditornmj
gmail.com
